Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal T cell subsets and lymphocyte activity in multiple sclerosis.

M M Albala, D Davignon, L D Fast

    Clinical and Experimental Immunology
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Resource allocation patterns of two California-Sonoran desert ephemerals.

    Oecologia·2017
    Same author

    Harnessing alloreactivity to achieve anti-leukemic responses.

    Leukemia supplements·2016
    Same author

    Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.

    Blood cancer journal·2015
    Same author

    The neutron imaging diagnostic at NIF (invited).

    The Review of scientific instruments·2012
    Same author

    Modeling the National Ignition Facility neutron imaging system.

    The Review of scientific instruments·2010
    Same author

    Mind, meaning and metaphor: the philosophy and psychology of metaphor in 19th-century Germany.

    History of the human sciences·2008
    Same journal

    Helios expression in naïve CD4+ T cells decreases from neonates to older adults.

    Clinical and experimental immunology·2026
    Same journal

    Could we discuss the molecular signature of immune dysregulation?

    Clinical and experimental immunology·2026
    Same journal

    The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

    Clinical and experimental immunology·2026
    Same journal

    PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

    Clinical and experimental immunology·2026
    Same journal

    Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

    Clinical and experimental immunology·2026
    Same journal

    Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

    Clinical and experimental immunology·2026
    See all related articles

    Lymphopheresis treatment for multiple sclerosis (MS) did not reveal underlying T-cell abnormalities. The therapy also did not significantly alter T-cell numbers or function in vitro.

    Area of Science:

    • Immunology
    • Neurology
    • Hematology

    Background:

    • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • T-cell dysregulation is implicated in the pathogenesis of MS.
    • Lymphopheresis is a therapeutic option explored for MS management.

    Purpose of the Study:

    • To investigate potential T-cell abnormalities in MS patients.
    • To evaluate the impact of lymphopheresis on T-cell populations and function in MS.
    • To determine if lymphopheresis alters T-cell profiles during treatment.

    Main Methods:

    • Nine patients with progressive or relapsing-remitting MS were treated with lymphopheresis.
    • Flow cytometry was used to analyze T-cell subsets (OKT3+, OKT4+, OKT8+).

    Related Experiment Videos

  • In vitro lymphocyte proliferation assays and natural killer cell activity tests were performed.

    • Main Results:

    • Patients initially showed lower OKT3+ cell percentages, which normalized after five treatments.
    • OKT4+ and OKT8+ cell levels remained within normal ranges and were unaffected by treatment.
    • Lymphocyte proliferation and natural killer cell activity were comparable to controls and unchanged by lymphopheresis.

    Conclusions:

    • The study does not support a fundamental T-cell abnormality in the studied MS patients.
    • Lymphopheresis treatment did not induce significant changes in T-cell numbers or in vitro functional activity.
    • These findings suggest lymphopheresis may not directly modulate T-cell immunity in MS.